A preliminary study of the anti-κ myeloma antigen monoclonal antibody KappaMab (MDX-1097) in pretreated patients with κ-restricted multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A preliminary study of the anti-κ myeloma antigen monoclonal antibody KappaMab (MDX-1097) in pretreated patients with κ-restricted multiple myeloma

Published:2019-07-31 Issue:8 Volume:9 Page:
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer J.

Author:

Spencer Andrew,Walker Patricia,Asvadi Parisa,Campbell Douglas H.,Reed Kate,Herbert Ben R.,Breen Edmond J.,Copeman Michael C.,Dunn Rosanne D.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/s41408-019-0217-5.pdf

Reference13 articles.

1. Fonseca, R. et al. Trends in overall survival and costs of multiple myeloma, 2000–2014. Leukemia 31, 1915–1921 (2017).

2. Drayson, M. et al. Effects of paraprotein heavy and light chain types and free light chain load on survival in myeloma: an analysis of patients receiving conventional-dose chemotherapy in Medical Research Council UK multiple myeloma trials. Blood 108, 2013–2019 (2006).

3. Anderson, K. C. & Carrasco, R. D. Pathogenesis of myeloma. Annu. Rev. Pathol. 6, 249–274 (2011).

4. Ludwig, H. et al. IMWG consensus on maintenance therapy in multiple myeloma. Blood 119, 3003–3015 (2012).

5. Lonial, S., Durie, B., Palumbo, A. & San-Miguel, J. Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectives. Leukemia 30, 526–535 (2016).

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A sequential cohort study evaluating single‐agent KappaMab and KappaMab combined with lenalidomide and low‐dose dexamethasone in relapsed and/or refractory kappa light chain‐restricted multiple myeloma (AMaRC 01‐16);British Journal of Haematology;2023-06-26

2. Changes in immune cell populations following KappaMab, lenalidomide and low‐dose dexamethasone treatment in multiple myeloma;Clinical & Translational Immunology;2023-01

3. Novel Antigens LMA and Kma Are Expressed on Malignant Bone Marrow Plasma Cells from Patients with Relapsed Refractory Multiple Myeloma and Plasma Cell Dyscrasias;Blood;2022-11-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3